Traders Lens

$DVA is the biggest loser in the S&P 500 for today so far. The stock is actually down because Ozempic, the drug from Novo Nordisk,…

$TALK, an online and mobile therapy company, has been on a steady uptrend the last 6 months. Looking at its weekly chart as well,  around…

$RVPH bottomed out in August of last year, at which time the company came out with positive trial results for their phase 2 study of…

In the latter part of 2022, $RLMD crashed after negative results for their drug REL-1017 in the treatment of depression. The drug failed to show…

$BNOX popped a few weeks ago after a positive update on their Phase 2b trial for PTSD. The drug, called BNC210 as of now, not…

Defense technology stocks are also getting a big boost today due to what’s happening in the middle east. The top 5 leaders on the S&P…

Oil is rallying today due to tensions in the middle east as a result $CVX is the leader on the Dow Jones right now.

$CYBN, a biopharmaceutical company focused on psychedelic based therapy for mental health conditions, had a nice run up in the latter part of September and…

$LGVN is falling for the second straight day after releasing trial data yesterday for their Alzheimer’s drug Lomecel-B

EV maker $RIVN is down today after announcing yesterday plans to issue $1.5 billion in convertible debt and reported preliminary third-quarter revenue

$ORTX, a gene therapy company gapped up today on news its being acquired by Kyowa Kirin Co, a Japan based pharmaceutical company for $16 a…

$GLMD continues to slide since announcing its pricing of a $7 million public offering on July 14th of this year. $GLMD has finished down in…